In Congo, the pregnant women living with hiv antiretroviral therapy coverage for pmtct is now 20%, representing a decrease of 1% (-4.8%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Congo
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Congo
PMTCT antiretroviral therapy coverage
More indicators for Congo
Male unintentional poisoning
1.6
0.0
(2019)
Female wasting in children
7.6%
+1.8%
(2014)
Female prevalence of HIV
3.6%
+0.2%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar30
-intl dollar9
(2021)
Birth registration
95.9%
+5.1%
(2015)
Contraceptive modern method prevalence
18.3%
-1.7%
(2015)
Congo PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 20% | -1% |
| 2021 | 21% | +9% |
| 2020 | 12% | +5% |
| 2019 | 7% | 0% |
| 2018 | 7% | -4% |
| 2017 | 11% | 0% |
| 2016 | 11% | -7% |
| 2015 | 18% | -2% |
| 2014 | 20% | -4% |
| 2013 | 24% | +5% |
| 2012 | 19% | -5% |
| 2011 | 24% | +13% |
| 2010 | 11% | +3% |
| 2009 | 8% | -9% |
| 2008 | 17% | +7% |
| 2007 | 10% | +5% |
| 2006 | 5% | +1% |
| 2005 | 4% | -2% |
| 2004 | 6% | +2% |
| 2003 | 4% | +2% |
| 2002 | 2% | +2% |
| 2001 | 0% | 0% |
| 2000 | 0% |